SEC 13F Intelligence

Rock Springs Capital Management LP / MDGL

Rock Springs Capital Management LP’s Madrigal Pharmaceuticals Inc Position

Does Rock Springs Capital Management LP own Madrigal Pharmaceuticals Inc (MDGL)? Yes — 171.0K shares worth $90M (+5.28% of its 13F portfolio) as of Q1 2026, up from 139.6K shares the prior filed quarter.

Position Value
$90M
Q1 2026
Shares
171.0K
% of Portfolio
+5.28%
Quarters Held
30
currently held

Position History MDGL

Reported value by quarter
Q4 ’18: $27MQ4 ’18Q1 ’19: $32MQ2 ’19: $27MQ3 ’19: $23MQ4 ’19: $23MQ4 ’19Q1 ’20: $17MQ2 ’20: $29MQ3 ’20: $30MQ4 ’20: $29MQ4 ’20Q1 ’21: $30MQ2 ’21: $26MQ3 ’21: $21MQ4 ’21: $23MQ4 ’21Q1 ’22: $27MQ2 ’22: $23MQ3 ’22: $21MQ4 ’22: $101MQ4 ’22Q1 ’23: $84MQ2 ’23: $46MQ3 ’23: $29MQ4 ’23: $46MQ4 ’23Q1 ’24: $76MQ2 ’24: $69MQ3 ’24: $56MQ4 ’24: $82MQ4 ’24Q1 ’25: $55MQ2 ’25: $42MQ3 ’25: $63MQ4 ’25: $81MQ4 ’25Q1 ’26: $90Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026171.0K$90M+5.28%
Q4 2025139.6K$81M+4.17%
Q3 2025137.7K$63M+3.69%
Q2 2025140.3K$42M+2.65%
Q1 2025166.7K$55M+3.16%
Q4 2024265.2K$82M+3.12%
Q3 2024263.1K$56M+1.82%
Q2 2024245.5K$69M+2.07%
Q1 2024285.9K$76M+1.94%
Q4 2023198.2K$46M+1.13%
Q3 2023196.4K$29M+0.77%
Q2 2023199.2K$46M+1.09%
Q1 2023348.1K$84M+2.01%
Q4 2022348.1K$101M+2.43%
Q3 2022317.5K$21M+0.53%
Q2 2022317.5K$23M+0.66%
Q1 2022273.5K$27M+0.68%
Q4 2021269.4K$23M+0.53%
Q3 2021262.5K$21M+0.44%
Q2 2021262.5K$26M+0.51%
Q1 2021258.5K$30M+0.66%
Q4 2020256.8K$29M+0.61%
Q3 2020254.3K$30M+0.77%
Q2 2020254.3K$29M+0.79%
Q1 2020250.0K$17M+0.69%
Q4 2019250.2K$23M+0.72%
Q3 2019272.4K$23M+0.94%
Q2 2019256.9K$27M+0.97%
Q1 2019255.3K$32M+1.23%
Q4 2018241.0K$27M+1.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of MDGL.